Types of amnesia after head injury8/11/2023 VIDEO: Chronic hormonal effects to look for following traumatic brain injury The FDA has approved two forms of empagliflozin as an adjunct to diet and exercise to improve glycemic control in children with type 2 diabetes, according to a press release. Read these and more top stories in endocrinology below:įDA approves empagliflozin for use among children with type 2 diabetes “It’s straightforward to test for pituitary hormone deficiencies, and any portion of a symptom that is directly due to a pituitary hormone deficiency should be reversible or significantly ameliorated by replacement ,” Wexler said. Wexler drew attention to pituitary hormone deficiencies, which can present “life-altering” symptoms after acquired brain injury - even a mild concussion. It was the top story in endocrinology last week.Īnother top story was an exclusive interview with Healio | Endocrine Today Editorial Board Member Tamara Wexler, MD, PhD. Both formulations have already been approved for adults. The FDA recently approved two forms of empagliflozin for kids with type 2 diabetes. The drugs by Eli Lilly and Boehringer Ingelheim were approved as an adjunct to diet and exercise after results from a double-blind, randomized, placebo-controlled trial showed that children who received empagliflozin had a 0.2% reduction in HbA1c compared with a 0.7% increase in the placebo group at 26 weeks. The FDA has approved new oral therapies for children with type 2 diabetes - empagliflozin and a combination of empagliflozin and metformin hydrochloride - for the first time in more than 20 years. If you continue to have this issue please contact to Healio
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |